Vetted Providers
Independently scored on a six-dimension public rubric. Transparent affiliate disclosure, never pay-to-rank.
5 providers
TrimRx
LegitScript-certified compounded GLP-1 telehealth
Strongest compliance posture in our initial GLP-1 cohort. LegitScript-certified at both the platform and pharmacy level, with transparent pricing and no major regulatory issues on record. Worth considering as a default option for users prioritizing cleaner sourcing over absolute lowest price.
$179-$259/mo (compounded sema/tirz)
No financial relationshipEden
Vertically-integrated GLP-1 telehealth with notable customer-service caveats
Eden has the most ambitious supply-chain story in our cohort — they own the pharmacy that fills your prescription, with a publicized per-lot testing program. The catch is the gap between the marketing and the operational record. BBB shows real complaint patterns around billing and refunds, ConsumerAffairs reinforces those themes, and a class-action investigation is examining whether Eden has been sharing health data with third-party advertisers. We list Eden because the structural advantages are real, but we score the experience-side dimensions honestly. If supply-chain integrity matters more to you than billing predictability, this is a contender. If you want predictable cancellation and refund handling, look elsewhere.
Flat-rate; varies by program tier
No financial relationshipRo
Established multi-vertical telehealth with insurance concierge for branded GLP-1
The strongest pick in our cohort for users with commercial insurance, hands down. The insurance concierge is a genuine differentiator: on Wegovy or Zepbound with eligible coverage and a manufacturer savings card, your monthly cost drops to $0-$25, which no all-inclusive cash-pay specialist can match. The catch is the multi-product compounder relationship: the April 2025 FDA finasteride alert reflects on Ro's vendor management broadly, and BBB complaints about membership-vs-medication billing transparency are recurring. Pure cash-pay users on compounded GLP-1 will find better value at TrimRx or Eden.
$45 first month, $145/mo + medication
No financial relationshipHims & Hers
Public-company telehealth, post-settlement branded-only GLP-1 supply
If you specifically want a brand-name GLP-1 from a public-company telehealth platform with mature compliance infrastructure, post-settlement Hims is a credible option, especially for the new oral Wegovy pill. The insurance pathway can drive Wegovy to $0-$25/month with eligible coverage. The honest counterweight: the September 2025 FDA warning letters and the messy 2025 break with Novo Nordisk are both recent enough that we are docking the score below where a clean operator would land. Trustpilot at 3.0/5 with 28% one-star reviews is worse than Ro's, and the BBB A+ does not fully offset that. For pure cash-pay compounded GLP-1, Hims no longer competes (compounded is wound down post-settlement); look at TrimRx or Eden.
$39 first month, $149/mo membership + $149-$299/mo medication
No financial relationshipHenry Meds
Cohort-cheapest compounded GLP-1, with the cohort-worst trust signals
If pure cash price is the only thing that matters and you're going in eyes wide open on the trust caveats, Henry Meds is the cohort's discount option, by a wide margin on oral semaglutide and oral tirzepatide. The honest counterweights are heavy: an F at the BBB with 25 unanswered complaints, a Trustpilot page that carries a suspected-fake-review notice (so the 4.5-star headline does not mean what it appears to mean), and an active Eli Lilly lawsuit over the way the company markets compounded tirzepatide. We list Henry Meds because the price difference is real for cost-sensitive readers, but the trust premium is on you. For most readers, TrimRx or Eden is the better starting point even if the monthly cost is higher.
$99-$449/mo depending on medication and form
No financial relationshipRefresh cadence
Quarterly public-record checks (state licenses, FDA warning letters, accreditation status), annual full-questionnaire reviews, and immediate re-scoring on any major event. Each provider profile shows a last verified date.
How we vet, in 30 seconds
Every provider above is scored on six dimensions. Public weights, public rationale, never pay-to-rank.
What we verify
- ·State pharmacy & clinic licenses
- ·FDA warning-letter database
- ·Accreditations (PCAB, LegitScript, USP <797>)
- ·Recall history + complaint patterns
The six dimensions
- ·Licensure (20%)
- ·Accreditation (20%)
- ·Transparency (20%)
- ·Product quality (15%)
- ·Pricing (15%)
- ·Customer service (10%)
What we disclose
- ·Every affiliate relationship per listing
- ·Weighting math behind every score
- ·Source URLs for every verification
- ·When something is stated but unverified
Head-to-head comparisons
Stuck between two? We pick a winner per use case so you can scan to the row that matches how you'd actually use the platform.
Henry Meds vs TrimRx
Independent head-to-head: Henry Meds vs TrimRx for compounded GLP-1. Why the price gap is real but the trust gap is bigger, and who should pick which.
See verdictRo vs Hims & Hers
Independent head-to-head: Ro vs Hims for Wegovy and Ozempic via telehealth. Insurance pathway, BBB rating, FDA history, real pricing, and who wins for which user.
See verdictTrimRx vs Eden
Independent head-to-head: TrimRx vs Eden for compounded semaglutide and tirzepatide. LegitScript, BBB ratings, vertical integration, pricing, and who wins for which user.
See verdictFrequently asked
About this directory, the rubric, and how we make money.
What does "vetted" mean here?
Each provider in this directory is independently scored on a public six-dimension rubric: licensure, accreditation, transparency, product quality, pricing, and customer service. We verify state pharmacy licenses against state board registries, FDA enforcement actions against the FDA warning-letter database, and accreditations against the relevant public registry where one exists. Every score has a one-line rationale and (where possible) a source link on the provider profile. The full methodology is at /methodology/provider-vetting.
Do you accept money from the providers you list?
Some providers in this directory have an affiliate relationship with us. When a reader clicks through and books a consultation, we may earn a per-click or per-qualified-consult fee. Inclusion in the directory is independent of whether a provider pays us. The rubric and ranking are not affected by who pays. Affiliate relationships are disclosed on every listing card with a "We earn a fee" pill, and the methodology page lists every compensation type we accept (per-click and per-qualified-consult only — never per-prescription).
Are compounded GLP-1 medications legal?
Yes, when prescribed by a licensed clinician and prepared by a state-licensed compounding pharmacy. Compounded versions are not FDA-approved (unlike brand-name Wegovy, Ozempic, Mounjaro, or Zepbound), but they are legally prepared at 503A pharmacies under individual prescriptions or at 503B FDA-registered outsourcing facilities. The legal landscape has evolved through 2025-2026; many telehealth providers offer both compounded and brand-name options. The FDA has not yet acted on most compounded telehealth platforms, but Eli Lilly and Novo Nordisk have filed lawsuits against several compounders over advertising claims.
How do you choose which providers to evaluate?
We start with the highest-trafficked telehealth platforms in each category (compounded GLP-1, brand-name GLP-1, longevity clinics, peptide compounding) and work down. Reader suggestions are prioritized in the next review cycle — email us via /contact with a name and a link.
Why is one provider ranked higher than another?
Because their weighted rubric score is higher. The score combines six dimensions with public weights: licensure (20%), accreditation (20%), transparency (20%), product quality (15%), pricing (15%), and customer service (10%). Each provider profile breaks down their score per dimension with a rationale, so you can see exactly which dimensions drove the ranking and disagree with specific scores if you want.
How often do you update this directory?
Public-record checks (state license, accreditation status, FDA warning letters) every quarter. The full Tier-3 questionnaire annually for active providers, and immediately whenever a major event happens (recall, regulatory action, ownership change, lawsuit). Each provider profile shows a "last verified" date so you can see how fresh the information is.
I had a bad experience with a provider you listed. What now?
Email us at /contact with details. If it's a one-off we note it and watch for patterns. If it's representative of broader issues, the listing comes down or gets re-scored. We'd rather de-list a provider than defend one we shouldn't have listed.
What if I have commercial insurance — should I still use these providers?
It depends. Compounded GLP-1 medications aren't covered by insurance regardless of provider — the cash-pay model is the model. If you have insurance that covers brand-name Wegovy, Ozempic, or Zepbound, providers with insurance concierge support (like Ro) become much more attractive because your effective monthly cost can drop to $0–$25 with savings cards and prior authorization. We try to flag these tradeoffs in each provider's "Best for / Look elsewhere if" section.
Have a question we didn't answer, or a provider you think we should evaluate?
Get in touch